Newsletter Signup | Community
1 in 4 Gleevec treated GIST patients has survived 10 years.
New Drug Shows Improved Outcomes for Patients with Advanced Metastatic Mid-gut Neuroendocrine Tumors
Surgery in Responding Patients Feasible for GIST
Increased Doses of Gleevec® More Effective in Gastrointestinal Stromal Tumors
Stivarga Approved for Advanced Gastrointestinal Stromal Tumors
Increased Doses of Gleevec® for Gleevec-Resistant Gastrointestinal Stromal Tumors (GIST) Effective
Surgery for Residual GIST May Improve Outcomes
SU11248 Effective in Gastrointestinal Stromal Tumors (GIST)
